Cannabis in the news August 7, 2019

Read Next Article →
News on cannabis stocks and on developments in the industry haven’t let up in today’s volatile markets. Here are this week’s stories that we believe will mean the most to you as a Canadian investor.

1.The Ontario securities commission has now opened an… Read More

Drug innovation will spur Pfizer’s dividend

PFIZER INC. $42 (New York symbol PFE; Income Portfolio, Manufacturing & Industry sector; Shares outstanding: 5.8 billion; Market cap: $243.6 billion; Dividend yield: 3.4%; Dividend Sustainability Rating: Highest; www.pfizer.com) is one of the world’s leading prescription drugmakers. Its top-selling brands include Lyrica (epilepsy), Celebrex (arthritis pain), Prevnar (pneumonia)… Read More

Spinoff plans enhance their prospects

GENERAL ELECTRIC CO. $8.98 (New York symbol GE, Manufacturing & Industry sector; Shares outstanding: 8.7 billion; Market cap: $78.1 billion; Dividend yield: 0.5%; Takeover Target Rating: Medium; www.ge.com) recently announced a major restructuring that will narrow its focus to three main businesses: aviation operations (jet engines and aircraft… Read More

Dividend Advisor Hotline – Friday, January 4, 2019

PFIZER INC., $43.00, New York symbol PFE, is one of the world’s largest makers of prescription drugs. Its top-selling brands include Lyrica (epilepsy), Celebrex (arthritis pain), Prevnar (pneumonia) and Enbrel (rheumatoid arthritis).

Starting with the March 2019 payment, Pfizer will increase its quarterly dividend by 5.9%,… Read More